Profile
HSG (HongShan Capital Group), formerly known as Sequoia China, is a leading venture capital and private equity firm investing globally in the technology, healthcare, and consumer sectors. With offices in Hong Kong, Shanghai, Beijing, Shenzhen, London, Tokyo, and Singapore, HSG manages over USD 55 billion in assets across various funds for top institutional investors.
Founded in 2005, HSG has nurtured entrepreneurship and innovation, backing more than 1,500 companies with transformative technologies, disruptive business models, and high-growth potential. To date, more than 160 HSG portfolio companies have listed on public stock exchanges, while over 140 private portfolio companies have reached unicorn status.
Throughout the past two decades, HSG has evolved into a fully integrated investment platform spanning seed, venture, growth, buyout, and infrastructure investing, as well as public equities investment.
HSG is committed to helping founders and companies build legendary companies that endure while consistently generating superior returns for our limited partners. By partnering with HSG, companies benefit from HSG’s extensive resources, including a robust entrepreneurial community and industry expertise.
Industry
Region of investment
HongShan Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
HongShan RMB Denominated Fund
|
Venture Capital (VC)
|
Financial Services
Fintech
Healthcare Services
Marketing and Advertising
Media and Entertainment
Robotics
Software
Transportation
HealthTech
|
Pre-seed
Seed
|
North America
Asia
|
$5-10 m
|
$2500 M
|
July 2024
|
|
HongShan Continuation Fund
|
Venture Capital (VC)
|
Financial Services
Fintech
Food and Beverage
Foodtech
Healthcare Services
Robotics
Software
Transportation
HealthTech
|
Pre-seed
Seed
|
North America
Asia
|
$5-10 m
|
$3000 M
|
May 2026
|